PillLevofloxacin
Levofloxacin
6 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 6 | SUPPLYING |
| Gland Pharma Limited | unknown | 5 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 3 | SUPPLYING |
| WG Critical Care, LLC | unknown | 3 | SUPPLYING |
| Hospira, Inc. | unknown | 3 | SUPPLYING |
| Baxter Healthcare Corporation | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 15, 2021RECALLRecall (Class II): Levofloxacin Injection in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) 24x100 mL Single Dose Flexible Containers…
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
- Sep 25, 2018RECALLRecall (Class III): Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24), …
Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution. — Recalling firm: Baxter Healthcare Corporation — Nationwide USA and Puerto Rico
- Aug 1, 2018RECALLRecall (Class III): Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag,…
Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution. — Recalling firm: Baxter Healthcare Corporation — Nationwide USA and Puerto Rico
- Aug 1, 2018RECALLRecall (Class III): Levofloxacin Injection in 5% Dextrose, 750 mg (5 mg/mL), 750 mg in 150 mL 5% Dextrose, 150 mL Single Use Container bag,…
Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution. — Recalling firm: Baxter Healthcare Corporation — Nationwide USA and Puerto Rico
- Aug 1, 2018RECALLRecall (Class III): Levofloxacin Injection in 5% Dextrose, 250 mg (5 mg/mL), 250 mg in 50 mL 5% Dextrose, 50 mL Single Use Container bag, R…
Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution. — Recalling firm: Baxter Healthcare Corporation — Nationwide USA and Puerto Rico
- Mar 10, 2017RECALLRecall (Class II): Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences In…
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product. — Recalling firm: Claris Lifesciences Inc — Nationwide